p16 promoter hypermethylation is associated with increased breast cancer risk

By            

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 904-908

Spandidos Publications

Access to resources Recommend Favorite

PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 1, 2011-01 ,pp. : 78-88

Bentham Science Publishers

Access to resources Recommend Favorite

Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa

By Kato Keizo   Hara Akira   Kuno Toshiya   Mori Hideki   Yamashita Tomomi   Toida Makoto   Shibata Toshiyuki  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 735-743

Springer Publishing Company

Access to resources Recommend Favorite

Rosiglitazone inhibits insulin-like growth factor1-induced polycystic kidney disease cell growth and p70S6 kinase activation

By          

Molecular Medicine Reports, Vol. 8, Iss. 3, 2013-01 ,pp. : 861-864

Spandidos Publications

Access to resources Recommend Favorite

Association Between MGMT Promoter Hypermethylation and p53 Mutation in Glioblastoma

By Shamsara Jamal   Sharif Samaneh   Afsharnezhad Sima   Lotfi Marzieh   Raziee Hamid Reza   Ghaffarzadegan Kamran   Moradi Afshin   Rahighi Saeed   Behravan Javad  

Cancer Investigation, Vol. 27, Iss. 8, 2009-10 ,pp. : 825-829

Informa Healthcare

Access to resources Recommend Favorite